Clinical Trial Update: Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Ga-68 PSMA ligand used to localize prostate cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ga-68 PSMA ligand (Ga-68 PSMA ligand)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Latent Cancer Prostate | Phase 2 | Status: COMPLETED